|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-9-7
|
|
pubmed:abstractText |
The recently published HRS/EHRA/ECAS AF Ablation Consensus Statement recommended that warfarin should be used for at least 2 months following an AF ablation in all patients regardless of stroke risk factors. The objective of the study was to assess outcomes based upon anticoagulation practice after atrial fibrillation (AF) ablation to determine relative risk of a strategy of aspirin only in low-risk patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1540-8167
|
|
pubmed:author |
pubmed-author:AndersonJeffrey LJL,
pubmed-author:AndersonLarsL,
pubmed-author:BairTami LTL,
pubmed-author:BunchT JaredTJ,
pubmed-author:CrandallBrian GBG,
pubmed-author:DayJohn DJD,
pubmed-author:FoleyThomasT,
pubmed-author:LappeDonald LDL,
pubmed-author:MayHeidi THT,
pubmed-author:MuhlesteinJ BrentJB,
pubmed-author:NelsonJenniferJ,
pubmed-author:OsbornJeffrey SJS,
pubmed-author:ScottAllisonA,
pubmed-author:WeissJ PeterJP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
988-93
|
|
pubmed:meshHeading |
pubmed-meshheading:19473299-Aged,
pubmed-meshheading:19473299-Anticoagulants,
pubmed-meshheading:19473299-Atrial Fibrillation,
pubmed-meshheading:19473299-Catheter Ablation,
pubmed-meshheading:19473299-Comorbidity,
pubmed-meshheading:19473299-Female,
pubmed-meshheading:19473299-Humans,
pubmed-meshheading:19473299-Incidence,
pubmed-meshheading:19473299-Male,
pubmed-meshheading:19473299-Middle Aged,
pubmed-meshheading:19473299-Postoperative Complications,
pubmed-meshheading:19473299-Risk Assessment,
pubmed-meshheading:19473299-Risk Factors,
pubmed-meshheading:19473299-Stroke,
pubmed-meshheading:19473299-Survival Analysis,
pubmed-meshheading:19473299-Survival Rate,
pubmed-meshheading:19473299-Therapeutics,
pubmed-meshheading:19473299-Warfarin
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.
|
|
pubmed:affiliation |
Intermountain Heart Rhythm Specialists, Intermountain Medical Center, Murray, Utah 84107, USA. Thomas.bunch@imail.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
